Literature DB >> 16452090

Competence of cranial ectoderm to respond to Fgf signaling suggests a two-step model of otic placode induction.

Kareen Martin1, Andrew K Groves.   

Abstract

Vertebrate craniofacial sensory organs derive from ectodermal placodes early in development. It has been suggested that all craniofacial placodes arise from a common ectodermal domain adjacent to the anterior neural plate, and a number of genes have been recently identified that mark such a 'pre-placodal' domain. However, the functional significance of this pre-placodal domain is still unclear. In the present study, we show that Fgf signaling is necessary and sufficient to directly induce some, but not all, markers of the otic placode in ectoderm taken from the pre-placodal domain. By contrast, ectoderm from outside this domain is not competent to express otic markers in response to Fgfs. Grafting naïve ectoderm into the pre-placodal domain causes upregulation of pre-placodal markers within 8 hours, together with the acquisition of competence to respond to Fgf signaling. This suggests a two-step model of craniofacial placode induction in which ectoderm first acquires pre-placodal region identity, and subsequently differentiates into particular craniofacial placodes under the influence of local inducing signals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452090     DOI: 10.1242/dev.02267

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  48 in total

Review 1.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 2.  Transcriptional regulation of cranial sensory placode development.

Authors:  Sally A Moody; Anthony-Samuel LaMantia
Journal:  Curr Top Dev Biol       Date:  2015-01-22       Impact factor: 4.897

3.  Canonical Wnt signaling is required for ophthalmic trigeminal placode cell fate determination and maintenance.

Authors:  Rhonda N T Lassiter; Carolynn M Dude; Stephanie B Reynolds; Nichelle I Winters; Clare V H Baker; Michael R Stark
Journal:  Dev Biol       Date:  2007-06-02       Impact factor: 3.582

4.  Mechanosensitive hair cell-like cells from embryonic and induced pluripotent stem cells.

Authors:  Kazuo Oshima; Kunyoo Shin; Marc Diensthuber; Anthony W Peng; Anthony J Ricci; Stefan Heller
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

5.  Notch signaling augments the canonical Wnt pathway to specify the size of the otic placode.

Authors:  Chathurani S Jayasena; Takahiro Ohyama; Neil Segil; Andrew K Groves
Journal:  Development       Date:  2008-05-21       Impact factor: 6.868

6.  Compensatory regulation of the size of the inner ear in response to excess induction of otic progenitors by fibroblast growth factor signaling.

Authors:  Jian Zhang; Kevin D Wright; Amanda A Mahoney Rogers; Molly M Barrett; Katherine Shim
Journal:  Dev Dyn       Date:  2014-06-12       Impact factor: 3.780

Review 7.  Setting appropriate boundaries: fate, patterning and competence at the neural plate border.

Authors:  Andrew K Groves; Carole LaBonne
Journal:  Dev Biol       Date:  2013-12-07       Impact factor: 3.582

Review 8.  The molecular basis of craniofacial placode development.

Authors:  Sunita Singh; Andrew K Groves
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-03-07       Impact factor: 5.814

9.  Specification of functional cranial placode derivatives from human pluripotent stem cells.

Authors:  Zehra Dincer; Jinghua Piao; Lei Niu; Yosif Ganat; Sonja Kriks; Bastian Zimmer; Song-Hai Shi; Viviane Tabar; Lorenz Studer
Journal:  Cell Rep       Date:  2013-11-27       Impact factor: 9.423

10.  Apoptosis and proliferation in the trigeminal placode.

Authors:  Wolfgang Knabe; Bastian Obermayer; Hans-Jürg Kuhn; Guido Brunnett; Stefan Washausen
Journal:  Brain Struct Funct       Date:  2009-11-14       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.